Thyroid Cancer Clinical Trials
There are over 600 live clinical trials for cancer in the UK today. Let us help you find the right trial for you.
RareCan is the only organisation in the UK that specialises in finding clinical trials for patients with rare cancer.
Please fill in the form to get started.
RareCan has over 50 members with thyroid cancer
RareCan has over 50 members with thyroid cancer
Prefer to do things by phone?
If you’d prefer to register by telephone, you can request a call-back by giving us your name and phone number below.
What is RareCan?
RareCan is a range of products and services that help you:
- Understand clinical trials and when they might an option for you
- Find trials that might be suitable for you now or in the future
- Get more detailed analysis of your tumour genetics to help identify potentially suitable clinical trials
- Understand genetics reports you have already had produced elsewhere and use them to find UK clinical trials
Book a free discovery call to find out if joining RareCan is right for you.
RareCan: Clinical Trial Service
£150 per year
- 1-2-1 telephone and email support from our experienced team
- A personalised report on potentially suitable clinical trials
- Updates to the report as new trials start or your situation changes
- Support to understand and discuss the report with your clinical team
RareCan: Insight
Price varies
- A range of high-precision multi-biomarker tests from blood or tissue samples that provide a detailed genomic profile of your tumour genetics
- A summary produced from an existing genetic report such as Guardent 360 or Foundation One to help you and your clinical team understand and use your existing report
Butterfly Thyroid Cancer Trust
Butterfly Thyroid Cancer Trust is the UK’s first national charity dedicated solely to supporting people with thyroid cancer. The organisation offers practical and emotional help from others who have experienced the disease, including a helpline, peer “buddy” support through treatment and recovery, and opportunities to connect with fellow patients. It also provides access to reliable information and in-clinic support at the Northern Centre for Cancer Care in Newcastle.
Summary of Thyroid Cancer
What is Thyroid Cancer?
Thyroid cancer occurs when cells in the thyroid gland — a small gland at the base of the neck responsible for producing hormones — begin to grow uncontrollably. Treatment typically involves surgery and may include radioactive iodine, targeted drugs or radiotherapy depending on the type and stage.
How rare is it?
In the UK there are around 4,000 new cases of thyroid cancer each year, which makes it roughly 1 % of all new cancer diagnoses. About 440 people die from it annually — it is not among the 20 most common causes of cancer death.
Who does it affect?
Thyroid cancer is more common in women than men, with around 2,900 new cases in females and 1,100 in males each year (2017-2019). Incidence rates are highest in people aged around 70-74, though survival is much better in younger people.
RareCan has over 3,000 members, here’s what some of them say.
The voices and experiences from our RareCan members, shared to help others on their own cancer journey.
“I joined RareCan to support research into my extremely rare and highly aggressive subtype of uterine cancer.”
— Lindy
RareCan Member
“I joined RareCan to get action and support and research on rare cancers”
— Steve
RareCan Member
“I joined RareCan because they have the solution to the challenges faced within rare cancer research.”
— Dave
RareCan Member
“I joined RareCan as it may help other people in the future.”
— Wayne
RareCan Member
“If my husband was alive today, he would encourage people to take part in research as you never know if you will ever need it in the future.”